CDEK
← All drugs Report issue

autologous mesenchymal stem cells

Cell therapyexperimental

Clinical trial activity

260 trials · 275 clinical orgs · 0 marketing orgs

Phase 1
164
Phase 2
145
Phase 3
21
Phase 4
1

Earliest trial started Nov 1, 1995 (NCT00705120)

Timeline

1990s

  1. Jan 1, 1995

    Earliest Phase 1 Sponsor(trial)

2000s

  1. Jan 1, 2005

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • adult mesenchymal stem cells
  • autologous mesenchymal cells
  • autologous mesenchymal stem cells
  • autologous mesenchymal stroma cells
  • autologous mesenchymal stromal cell
  • autologous mesenchymal stromal cells
  • mesenchymal cells
  • mesenchymal precursor cells
  • mesenchymal stem cell
  • mesenchymal stem cells
  • mesenchymal stem cells
  • mesenchymal stromal cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06798623Phase 1Oct 31, 2025The University of Texas, Dallas
NCT07212335Early Phase 1 (Phase 1)Oct 1, 2025China Academy of Chinese Medical Sciences
NCT07192211Phase 2Sep 30, 2025Osaka University, Rohto Pharmaceutical Co., Ltd.
NCT07070934Phase 2Jul 15, 2025Xuzhou Medical University
NCT06858254Phase 1/Phase 2 (Phase 2)Apr 1, 2025Apeiron Biologics, University of Colorado, Boulder
NCT02503280Phase 1/Phase 2 (Phase 2)Mar 1, 2025University of Miami
NCT06793449Phase 2Feb 5, 2025China Academy of Chinese Medical Sciences
NCT05939167Phase 1/Phase 2 (Phase 2)Dec 10, 2023Capital Medical University, Fifth Hospital of Shijiazhuang City, People's Liberation Army of China, Shenzhen Third People's Hospital
NCT05789719Phase 1Nov 1, 2023StemMedical
NCT05936060Phase 2Oct 1, 2023Hospital Infantil Universitario de San Jose, Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud
NCT05784519Early Phase 1 (Phase 1)Jun 1, 2023Nanjing University
NCT05675319Phase 3Mar 3, 2023Gemeinsamer Bundesausschuss, Staburo GmbH, University of Hamburg
NCT05433298Phase 1/Phase 2 (Phase 2)May 1, 2022Conselho Nacional de Desenvolvimento Científico e Tecnológico, Pontifícia Universidade Católica do Paraná
NCT04595890Phase 2Jan 1, 2022University of Delaware
NCT05167721Phase 2Dec 15, 2021Mayo Clinic
NCT04735185N/ANov 30, 2021Department of Defense, Johns Hopkins University, The Geneva Foundation
NCT04888949Phase 2Jun 15, 2021Rohto Pharmaceutical Co., Ltd.
NCT04750252Phase 1/Phase 2 (Phase 2)Feb 22, 2021Akan Biosciences, LLC
NCT04432467Phase 1/Phase 2 (Phase 2)Oct 1, 2020Belarusian Medical Academy of Post-Graduate Education, Belarusian State Medical University, National Academy of Sciences of Belarus
NCT04522986Phase 1Sep 30, 2020Osaka University, Rohto Pharmaceutical Co., Ltd.
Showing 20 of 260 trials
Page 1 / 13

Organizations

Research & Development (275)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment231042008
Sun Yat-Sen UniversityAcademic/Hospital15542009
Southern Medical UniversityAcademic/Hospital13832013
Royan InstituteAcademic/Hospital111132009
Mesoblast, Inc.For profit101032005
National Heart, Lung, and Blood Institute (NHLBI)Government10012007
Mayo ClinicAcademic/Hospital9922010
Shantou UniversityAcademic/Hospital8222009
University of MiamiAcademic/Hospital8722007
Guangzhou Medical UniversityAcademic/Hospital7022013
Banc de Sang i TeixitsAcademic/Hospital6612012
Case Western Reserve UniversityAcademic/Hospital6522011
Chinese Academy of Medical SciencesAcademic/Hospital6642011
Karolinska InstituteAcademic/Hospital6622011
Mario Negri InstituteAcademic/Hospital6422008
Peking UniversityAcademic/Hospital6022013
University of JordanAcademic/Hospital6522012
University of LondonAcademic/Hospital6322008
University of Texas at HoustonAcademic/Hospital6622008
Icahn School of Medicine at Mount SinaiAcademic/Hospital5522009
275 organizations
Page 1 / 14